Topical Corticosteroid-Induced Adrenal Insufficiency: A Case Report
- PMID: 35496505
- PMCID: PMC8995654
- DOI: 10.1159/000515734
Topical Corticosteroid-Induced Adrenal Insufficiency: A Case Report
Abstract
Topical Corticosteroids (TCS) are the most commonly prescribed medications in Dermatology practice. They are considered safe and effective if used at the appropriate location and for the appropriate duration. Local side effects due to TCS are not uncommon. However, systemic side effects are rare. Herein, we present a patient who developed adrenal insufficiency secondary to the use of TCS.
Keywords: Adrenal insufficiency; Adrenal suppression; Side effects; Topical corticosteroids.
Copyright © 2022 by S. Karger AG, Basel.
Conflict of interest statement
The authors declare that there is no conflict of interest.
References
-
- Gual A, Pau-Charles I, Abeck D. Topical corticosteroids in dermatology: from chemical development to galenic innovation and therapeutic trends. J Clin Exp Dermatol Res. 2015;6:2.
-
- Mehta AB, Nadkarni NJ, Patil SP, Godse KV, Gautam M, Agarwal S. Topical corticosteroids in dermatology. Indian J Dermatol Venereol Leprol. 2016;82((4)):371–8. - PubMed
-
- Kragballe K. Topical corticosteroids: mechanisms of action. Acta Derm Venereol Suppl. 1989;151:7–52. - PubMed
Publication types
LinkOut - more resources
Full Text Sources